Related Experiment Video
Updated: May 10, 2025

07:05
Perfusable Vascular Network with a Tissue Model in a Microfluidic Device
Published on: April 4, 2018
13.8K
Reinforcing Stromal Cell Spheroid Through Red-Light Preconditioning for Advanced Vascularization.
Yu-Jin Kim1,2, Hyeok Kim2, Dong-Hyun Lee1
1School of Chemical Engineering, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|April 25, 2025
Summary
This study enhances stromal cell therapy for heart attack recovery by using special light (OLED-based photobiomodulation) and 3D cell structures. These engineered cells improve cardiac function and reduce damage after myocardial infarction (MI).
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Biomedical Engineering
Background:
- Stromal cell therapy shows promise for myocardial infarction (MI) but suffers from poor cell retention.
- Existing methods struggle to maintain cell viability and therapeutic efficacy in the ischemic cardiac environment.
Purpose of the Study:
- To develop an improved stromal cell therapy for post-MI cardiac repair.
- To investigate the synergistic effects of photobiomodulation preconditioning and 3D spheroid culture for human adipose-derived stromal cells (hADSCs).
Main Methods:
- Human adipose-derived stromal cells (hADSCs) were preconditioned using OLED-based photobiomodulation (OPBM).
- Preconditioned hADSCs were cultured into 3D spheroids.
- The therapeutic efficacy of these preconditioned 3D spheroids (APCS group) was evaluated in a rat model of MI.
Main Results:
- The APCS group demonstrated significantly enhanced angiogenic, arterialized, and tissue remodeling capabilities compared to 2D cultures and non-preconditioned spheroids.
- In vivo transplantation improved cardiac function and reduced adverse remodeling.
- Enhanced anti-fibrosis and angiogenesis, including arterialization, were observed post-transplantation.
Conclusions:
- Combining OPBM preconditioning with 3D spheroid culture significantly enhances the therapeutic potential of hADSCs for cardiac repair.
- This novel approach overcomes limitations of traditional stromal cell therapy in post-MI heart failure.
- The strategy offers a next-generation cell therapeutic for myocardial infarction treatment.

